The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant sacituzumab govitecan in patients with muscle-invasive bladder cancer: Final results and biomarker analyses of the SURE-01 trial.
 
Brigida Anna Maiorano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Johnson & Johnson/Janssen; Merck Serono; MSD
Research Funding - Merck
Travel, Accommodations, Expenses - Ipsen; Janssen; Novartis; Pfizer
 
Joep de Jong
No Relationships to Disclose
 
Antonio Cigliola
No Relationships to Disclose
 
Chiara Mercinelli
No Relationships to Disclose
 
James Proudfoot
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Giuseppe Basile
No Relationships to Disclose
 
Valentina Tateo
No Relationships to Disclose
 
Michela Piacentini
No Relationships to Disclose
 
Enrico Tomasi
No Relationships to Disclose
 
Elai Davicioni
No Relationships to Disclose
 
Marco Moschini
No Relationships to Disclose
 
Giorgio Brembilla
Travel, Accommodations, Expenses - Bracco Diagnostics
 
Maurizio Colecchia
No Relationships to Disclose
 
Francesco De Cobelli
Expert Testimony - Bayer
 
Jeffrey Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Tango Therapeutics
Research Funding - Foundation Medicine
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Candice Francheska Tambaoan
Employment - Foundation Medicine
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Roche
Travel, Accommodations, Expenses - Foundation Medicine
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ferring; Hauora; Janssen-Cilag; MDxHealth; OPKO Health; Pfizer
Speakers' Bureau - Astellas Pharma
Research Funding - Merck Sharp & Dohme; Sandoz-Novartis
 
Francesco Montorsi
No Relationships to Disclose
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Johnson & Johnson/Janssen; Merck Serono; Merck Sharp & Dohme; Peerview; PeerVoice; Samsung Bioepis; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Janssen; Merck Sharp & Dohme